Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
Peter R Millar,Brian A Gordon,Patrick H Luckett,Tammie L S Benzinger,Carlos Cruchaga,Anne M Fagan,Jason J Hassenstab,Richard J Perrin,Suzanne E Schindler,Ricardo F Allegri,Gregory S Day,Martin R Farlow,Hiroshi Mori,Georg Nübling,Dominantly Inherited Alzheimer Network,Randall J Bateman,John C Morris,Beau M Ances,Adam Sarah,Allegri Ricardo,Araki Aki,Barthelemy Nicolas,Bateman Randall,Bechara Jacob,Benzinger Tammie,Berman Sarah,Bodge Courtney,Brandon Susan,Brooks William Bill,Brosch Jared,Buck Jill,Buckles Virginia,Carter Kathleen,Cash Lisa,Chen Charlie,Chhatwal Jasmeer,Mendez Patricio C,Chua Jasmin,Chui Helena,Courtney Laura,Cruchaga Carlos,Day Gregory S,DeLaCruz Chrismary,Denner Darcy,Diffenbacher Anna,Dincer Aylin,Donahue Tamara,Douglas Jane,Duong Duc,Egido Noelia,Esposito Bianca,Fagan Anne,Farlow Marty,Feldman Becca,Fitzpatrick Colleen,Flores Shaney,Fox Nick,Franklin Erin,Joseph-Mathurin Nelly,Fujii Hisako,Gardener Samantha,Ghetti Bernardino,Goate Alison,Goldberg Sarah,Goldman Jill,Gonzalez Alyssa,Gordon Brian,Gräber-Sultan Susanne,Graff-Radford Neill,Graham Morgan,Gray Julia,Gremminger Emily,Grilo Miguel,Groves Alex,Haass Christian,Häsler Lisa,Hassenstab Jason,Hellm Cortaiga,Herries Elizabeth,Hoechst-Swisher Laura,Hofmann Anna,Holtzman David,Hornbeck Russ,Igor Yakushev,Ihara Ryoko,Ikeuchi Takeshi,Ikonomovic Snezana,Ishii Kenji,Jack Clifford,Jerome Gina,Johnson Erik,Jucker Mathias,Karch Celeste,Käser Stephan,Kasuga Kensaku,Keefe Sarah,Klunk William,Koeppe Robert,Koudelis Deb,Kuder-Buletta Elke,Laske Christoph,Levey Allan,Levin Johannes,Li Yan,Lopez M D Oscar,Marsh Jacob,Martins Ralph,Mason Neal S,Masters Colin,Mawuenyega Kwasi,McCullough Austin,McDade Eric,Mejia Arlene,Morenas-Rodriguez Estrella,Morris John,Mountz James,Mummery Cath,Nadkarni Neelesh,Nagamatsu Akemi,Neimeyer Katie,Niimi Yoshiki,Noble James,Norton Joanne,Nuscher Brigitte,Obermüller Ulricke,O'Connor Antoinette,Patira Riddhi,Perrin Richard,Ping Lingyan,Preische Oliver,Renton Alan,Ringman John,Salloway Stephen,Schofield Peter,Senda Michio,Seyfried Nicholas T,Shady Kristine,Shimada Hiroyuki,Sigurdson Wendy,Smith Jennifer,Smith Lori,Snitz Beth,Sohrabi Hamid,Stephens Sochenda,Taddei Kevin,Thompson Sarah,Vöglein Jonathan,Wang Peter,Wang Qing,Weamer Elise,Xiong Chengjie,Xu Jinbin,Xu Xiong
DOI: https://doi.org/10.7554/eLife.81869
IF: 7.7
2023-01-06
eLife
Abstract:Background: Estimates of 'brain-predicted age' quantify apparent brain age compared to normative trajectories of neuroimaging features. The brain age gap (BAG) between predicted and chronological age is elevated in symptomatic Alzheimer disease (AD) but has not been well explored in presymptomatic AD. Prior studies have typically modeled BAG with structural MRI, but more recently other modalities, including functional connectivity (FC) and multimodal MRI, have been explored. Methods: We trained three models to predict age from FC, structural (S), or multimodal MRI (S+FC) in 390 amyloid-negative cognitively normal (CN/A-) participants (18-89 years old). In independent samples of 144 CN/A-, 154 CN/A+, and 154 cognitively impaired (CI; CDR > 0) participants, we tested relationships between BAG and AD biomarkers of amyloid and tau, as well as a global cognitive composite. Results: All models predicted age in the control training set, with the multimodal model outperforming the unimodal models. All three BAG estimates were significantly elevated in CI compared to controls. FC-BAG was significantly reduced in CN/A+ participants compared to CN/A-. In CI participants only, elevated S-BAG and S+FC BAG were associated with more advanced AD pathology and lower cognitive performance. Conclusions: Both FC-BAG and S-BAG are elevated in CI participants. However, FC and structural MRI also capture complementary signals. Specifically, FC-BAG may capture a unique biphasic response to presymptomatic AD pathology, while S-BAG may capture pathological progression and cognitive decline in the symptomatic stage. A multimodal age-prediction model improves sensitivity to healthy age differences. Funding: This work was supported by the National Institutes of Health (P01-AG026276, P01- AG03991, P30-AG066444, 5-R01-AG052550, 5-R01-AG057680, 1-R01-AG067505, 1S10RR022984-01A1, and U19-AG032438), the BrightFocus Foundation (A2022014F), and the Alzheimer's Association (SG-20-690363-DIAN).